Flagship Ventures Fund IV General Partner LLC, Ten Percent Owner at Rubius Therapeutics, holds 7.93M shares in Evelo Biosciences (Ticker: EVLO), holds 29.25M shares in Axcella Health (Ticker: AXLA), holds 17.25M shares in Rubius Therapeutics (Ticker: RUBY). Most recently, Flagship Ventures Fund IV General Partner LLC Bought ― shares of Evelo Biosciences on Jul 13, 2023 for an estimated value of 12.50M.